Wang Yuanyong, Zhang Jin, Yang Yuchen, Liu Zhuofeng, Sun Sijia, Li Rui, Zhu Hui, Li Tian, Zheng Jin, Li Jie, Ma Litian
Department of Thoracic Surgery Tangdu Hospital Air Force Medical University Xi'an China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) The First Department of Thoracic Surgery Peking University Cancer Hospital and Institute Peking University School of Oncology Beijing China.
MedComm (2020). 2024 Sep 4;5(9):e699. doi: 10.1002/mco2.699. eCollection 2024 Sep.
Circular RNAs (circRNAs) are a unique class of RNA molecules formed through back-splicing rather than linear splicing. As an emerging field in molecular biology, circRNAs have garnered significant attention due to their distinct structure and potential functional implications. A comprehensive understanding of circRNAs' functions and potential clinical applications remains elusive despite accumulating evidence of their involvement in disease pathogenesis. Recent research highlights their significant roles in various human diseases, but comprehensive reviews on their functions and applications remain scarce. This review provides an in-depth examination of circRNAs, focusing first on their involvement in non-neoplastic diseases such as respiratory, endocrine, metabolic, musculoskeletal, cardiovascular, and renal disorders. We then explore their roles in tumors, with particular emphasis on exosomal circular RNAs, which are crucial for cancer initiation, progression, and resistance to treatment. By detailing their biogenesis, functions, and impact on disease mechanisms, this review underscores the potential of circRNAs as diagnostic biomarkers and therapeutic targets. The review not only enhances our understanding of circRNAs' roles in specific diseases and tumor types but also highlights their potential as novel diagnostic and therapeutic tools, thereby paving the way for future clinical investigations and potential therapeutic interventions.
MedComm (2020). 2024-9-4
Comput Struct Biotechnol J. 2021-1-22
Cancer Lett. 2024-4-28
Front Cardiovasc Med. 2023-3-20
Front Mol Biosci. 2021-11-19
Pharmacol Ther. 2022-4
CNS Neurol Disord Drug Targets. 2022-8-29
Mater Today Bio. 2025-7-4
Avicenna J Med Biotechnol. 2025
Naunyn Schmiedebergs Arch Pharmacol. 2025-5-6
Cell Death Discov. 2025-4-24
Arch Dermatol Res. 2025-4-5
MedComm (2020). 2025-2-2
Int J Mol Sci. 2024-12-19
Metabolites. 2023-10-10